Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women [2]

Blood

Volumn 105, Issue 8, 2005, Pages 3382-

  Mannucci, Pier Mannuccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN;

AMNIOCENTESIS; BLEEDING; BODY WEIGHT; CHORION VILLUS; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; FLUID INTAKE; FLUSHING; GESTATIONAL AGE; HEADACHE; HEMOPHILIA A; HUMAN; LABORATORY TEST; LETTER; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; SPONTANEOUS ABORTION; TREATMENT OUTCOME; WEIGHT GAIN; X CHROMOSOME INACTIVATION;

EID: 17044373272     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-11-4472     Document Type: Letter

References (5)

1. Cohen AJ, Kessler CM, Ewenstein BM. Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia. 2001;7:235-241.
2. Kujovich JL. Von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246-253.
3. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv. 1998;53:450-455.
4. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood. 1997;90:2515-2521.
5. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977;1:869-872.